文献速递消化道肿瘤与早癌消化内镜

老年早期胃癌内镜切除适应证与治愈性标准扩展的前瞻性队列研究

Potential for expanding indications and curability criteria of endoscopic resection for early gastric cancer in elderly patients: results from a Japanese multicenter prospective cohort study.
PubMed 文献 · Gastrointest Endosc · 2024-01-23

该日本多中心前瞻性队列纳入≥75岁早期胃癌患者3371例、病变3821处,评估内镜切除的临床结局并探索新的适应证与治愈性标准。结果显示,适应范围内病变整块切除率98.9%、R0切除率94.4%、穿孔率0.8%;治愈性切除后5年胃癌累积死亡率为0.3%。研究提示≤3 cm病变及老年低危(EL-L)可分别作为新的内镜切除适应证与治愈性标准。

要点

  • 适应范围内病变整块切除率98.9%、R0切除率94.4%、穿孔率0.8%
  • 治愈性内镜切除后5年胃癌累积死亡率仅0.3%(95%CI 0.2-0.6)
  • ≤3 cm病变与EL-L(估计转移风险≤10%)可考虑作为新的适应证与治愈性标准

核心结论

  • 对老年早期胃癌患者,内镜黏膜下剥离术的临床结局支持其应用价值。
  • ≤3 cm的病变和EL-L分别成为新的内镜切除适应证和治愈性标准。

研究设计与样本

  • 日本多中心前瞻性队列研究,纳入年龄≥75岁、接受内镜切除的早期胃癌患者。
  • 共纳入3371例患者、3821处早期胃癌病变;内镜黏膜下剥离术为主要治疗方式。
  • 将eCuraC-2(对应日本胃癌治疗指南定义的非治愈性切除)分为老年高危(估计转移风险>10%)与老年低危(EL-L,估计转移风险≤10%)。

主要发现

  • 适应范围内病变的整块切除率、R0切除率和穿孔率分别为98.9%、94.4%和0.8%。
  • 超出适应证的病变中,≤3 cm者整块切除率99.5%、R0切除率85.4%、穿孔率5.9%;>3 cm者分别为96.0%、64.0%、18.0%。
  • 适应范围内病变中治愈性切除占83.6%、EL-L占6.2%;超出适应证的<3 cm病变中分别占44.2%和16.8%。
  • 治愈性内镜切除后5年胃癌累积死亡率为0.3%(95%CI 0.2-0.6),老年高危组为3.5%(95%CI 2.0-5.7)。
  • EL-L组即使未接受后续治疗,5年胃癌累积死亡率也为0.9%(95%CI 0.2-3.5)。

关键数值与推荐

  • 适应范围内病变:整块切除率98.9%、R0切除率94.4%、穿孔率0.8%。
  • 超出适应证且≤3 cm病变:整块切除率99.5%、R0切除率85.4%、穿孔率5.9%。
  • 超出适应证且>3 cm病变:整块切除率96.0%、R0切除率64.0%、穿孔率18.0%。
  • EL-L定义为eCuraC-2中估计转移风险≤10%者,老年高危为估计转移风险>10%者。
  • 治愈性切除后5年胃癌累积死亡率0.3%(95%CI 0.2-0.6);EL-L未后续治疗者为0.9%(95%CI 0.2-3.5)。

临床怎么用

  • 对≥75岁早期胃癌患者,可依据病变大小(≤3 cm)与EL-L分层评估内镜切除的可行性。
  • EL-L病变即使未接受后续治疗,5年胃癌死亡风险也较低,可为个体化决策提供依据。
  • 临床需结合整块切除率、R0切除率与穿孔风险综合权衡超适应证切除的获益与风险。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Evidence for endoscopic resection (ER) in elderly patients with early gastric cancer (EGC) is limited. We assessed its clinical outcomes and explored new indications and curability criteria. METHODS: We analyzed data from a Japanese multicenter, prospective cohort study. Patients aged ≥75 years with EGC treated with ER were included. We classified eCuraC-2 (corresponding to noncurative ER, defined in the Japanese gastric cancer treatment guidelines) into elderly-high (>10% estimated metastatic risk) and elderly-low (EL-L) (≤10% estimated metastatic risk). RESULTS: In total, 3371 patients with 3821 EGCs were included; endoscopic submucosal dissection was the prominent treatment choice. Among them, 3586 lesions met the guidelines' ER indications, and 235 did not. The proportions of en bloc and R0 resections and perforations were 98.9%, 94.4%, and 0.8%, respectively, in EGCs within the indications. In EGCs beyond the indications, they were 99.5%, 85.4%, and 5.9%, respectively, for lesions diagnosed as ≤3 cm and 96.0%, 64.0%, and 18.0%, respectively, for those >3 cm. Curative ER and EL-L were observed in 83.6% and 6.2% of lesions within the indications, respectively, and in 44.2% and 16.8% of lesions <3 cm beyond the indications, respectively. The 5-year cumulative gastric cancer death rates after curative ER and elderly-high were 0.3% (95% confidence interval [CI], 0.2-0.6) and 3.5% (95% CI, 2.0-5.7), respectively. After EL-L, the rate was 0.9% (95% CI, 0.2-3.5) even without subsequent treatment. CONCLUSIONS: The usefulness of endoscopic submucosal dissection for elderly EGC patients was confirmed by their clinical outcomes. Lesions of ≤3 cm and EL-L emerged as new ER indication and curability criteria, respectively. (Clinical trial registration number: UMIN000005871.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Sekiguchi M, Suzuki H, Takizawa K, et al. Potential for expanding indications and curability criteria of endoscopic resection for early gastric cancer in elderly patients: results from a Japanese multicenter prospective cohort study. Gastrointest Endosc. 2024. PMID: 38272277. doi:10.1016/j.gie.2024.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。